Viridian Therapeutics Correlations

0K1R Stock

14.98 0.32 2.09%

The correlation of Viridian Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Viridian Therapeutics Correlation With Market

Significant diversification

The correlation between Viridian Therapeutics and DJI is 0.08 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Viridian Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Viridian Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Viridian Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Viridian Therapeutics to buy it.

Moving together with Viridian Stock

0.63	TYT	Toyota Motor Corp	Pair Corr
0.68	SBID	State Bank	Pair Corr

Moving against Viridian Stock

0.85	0KII	SSAB AB ser	Pair Corr
0.78	0QYR	Panasonic Corp	Pair Corr
0.55	SMSN	Samsung Electronics	Pair Corr
0.54	BC94	Samsung Electronics	Pair Corr
0.48	SMSD	Samsung Electronics	Pair Corr

Related Correlations Analysis

	PFD	0RFX	DFIB	SUPR	MONY	0DNW	0NY8	0NYH
PFD		0.2	0.0	-0.16	-0.11	0.4	-0.31	0.21	PFD
0RFX	0.2		0.0	-0.68	-0.61	-0.31	-0.66	-0.62	0RFX
DFIB	0.0	0.0		0.0	0.0	0.0	0.0	0.0	DFIB
SUPR	-0.16	-0.68	0.0		0.85	0.02	0.86	0.69	SUPR
MONY	-0.11	-0.61	0.0	0.85		0.01	0.73	0.6	MONY
0DNW	0.4	-0.31	0.0	0.02	0.01		-0.15	0.54	0DNW
0NY8	-0.31	-0.66	0.0	0.86	0.73	-0.15		0.49	0NY8
0NYH	0.21	-0.62	0.0	0.69	0.6	0.54	0.49		0NYH
	PFD	0RFX	DFIB	SUPR	MONY	0DNW	0NY8	0NYH

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

0NY8	+ 0.86	SUPR
MONY	+ 0.85	SUPR
0NY8	+ 0.73	MONY
0NYH	+ 0.69	SUPR
0NYH	+ 0.6	MONY
0NYH	+ 0.54	0DNW

High negative correlations

SUPR	- 0.68	0RFX
0NY8	- 0.66	0RFX
0NYH	- 0.62	0RFX
MONY	- 0.61	0RFX
0DNW	- 0.31	0RFX
0NY8	- 0.31	PFD

Risk-Adjusted Indicators

There is a big difference between Viridian Stock performing well and Viridian Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Viridian Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PFD	0.83	(0.07)	0.00	(0.21)	0.00	0.00	1.85	(1.48)	4.44
0RFX	0.96	(0.06)	0.00	3.92	0.00	0.00	2.40	(2.05)	7.24
DFIB	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
SUPR	1.05	0.22	0.19	(1.51)	0.92	(1.27)	2.65	(1.70)	6.69
MONY	1.09	0.07	0.05	0.37	1.22	(1.14)	2.12	(2.14)	7.39
0DNW	1.01	0.09	0.07	0.18	1.19	(1.10)	2.04	(1.85)	6.89
0NY8	0.80	0.26	0.23	2.97	0.74	(0.91)	2.43	(1.80)	4.91
0NYH	0.44	0.07	0.12	(1.15)	0.39	(0.53)	1.13	(0.93)	2.92

Be your own money manager

Our tools can tell you how much better you can do entering a position in Viridian Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stocks Directory Now

Stocks Directory

Find actively traded stocks across global markets

All Next

Launch Module

Viridian Therapeutics Corporate Management

Elected by the shareholders, the Viridian Therapeutics' board of directors comprises two types of representatives: Viridian Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Viridian. The board's role is to monitor Viridian Therapeutics' management team and ensure that shareholders' interests are well served. Viridian Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Viridian Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.

MD MBA	Chief Officer	Profile
Seth Harmon	Principal Accounting	Profile
Anthony Casicano	Chief Officer	Profile
Melissa Manno	Chief Officer	Profile
John Jordan	Vice Communications	Profile
Anthony Casciano	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC